Cargando…
A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome
Mitochondrial DNA depletion syndrome (MDS) is a group of severe inherited disorders caused by mutations in genes, such as deoxyribonucleoside kinase (DGUOK). A great majority of DGUOK mutant MDS patients develop iron overload progressing to severe liver failure. However, the pathological mechanisms...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132052/ https://www.ncbi.nlm.nih.gov/pubmed/34026460 http://dx.doi.org/10.1002/advs.202004680 |
_version_ | 1783694841339707392 |
---|---|
author | Guo, Jingyi Duan, Lifan He, Xueying Li, Shengbiao Wu, Yi Xiang, Ge Bao, Feixiang Yang, Liang Shi, Hongyan Gao, Mi Zheng, Lingjun Hu, Huili Liu, Xingguo |
author_facet | Guo, Jingyi Duan, Lifan He, Xueying Li, Shengbiao Wu, Yi Xiang, Ge Bao, Feixiang Yang, Liang Shi, Hongyan Gao, Mi Zheng, Lingjun Hu, Huili Liu, Xingguo |
author_sort | Guo, Jingyi |
collection | PubMed |
description | Mitochondrial DNA depletion syndrome (MDS) is a group of severe inherited disorders caused by mutations in genes, such as deoxyribonucleoside kinase (DGUOK). A great majority of DGUOK mutant MDS patients develop iron overload progressing to severe liver failure. However, the pathological mechanisms connecting iron overload and hepatic damage remains uncovered. Here, two patients’ skin fibroblasts are reprogrammed to induced pluripotent stem cells (iPSCs) and then corrected by CRISPR/Cas9. Patient‐specific iPSCs and corrected iPSCs‐derived high purity hepatocyte organoids (iHep‐Orgs) and hepatocyte‐like cells (iHep) are generated as cellular models for studying hepatic pathology. DGUOK mutant iHep and iHep‐Orgs, but not control and corrected one, are more sensitive to iron overload‐induced ferroptosis, which can be rescued by N‐Acetylcysteine (NAC). Mechanically, this ferroptosis is a process mediated by nuclear receptor co‐activator 4 (NCOA4)‐dependent degradation of ferritin in lysosome and cellular labile iron release. This study reveals the underlying pathological mechanisms and the viable therapeutic strategies of this syndrome, and is the first pure iHep‐Orgs model in hereditary liver diseases. |
format | Online Article Text |
id | pubmed-8132052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81320522021-05-21 A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome Guo, Jingyi Duan, Lifan He, Xueying Li, Shengbiao Wu, Yi Xiang, Ge Bao, Feixiang Yang, Liang Shi, Hongyan Gao, Mi Zheng, Lingjun Hu, Huili Liu, Xingguo Adv Sci (Weinh) Research Articles Mitochondrial DNA depletion syndrome (MDS) is a group of severe inherited disorders caused by mutations in genes, such as deoxyribonucleoside kinase (DGUOK). A great majority of DGUOK mutant MDS patients develop iron overload progressing to severe liver failure. However, the pathological mechanisms connecting iron overload and hepatic damage remains uncovered. Here, two patients’ skin fibroblasts are reprogrammed to induced pluripotent stem cells (iPSCs) and then corrected by CRISPR/Cas9. Patient‐specific iPSCs and corrected iPSCs‐derived high purity hepatocyte organoids (iHep‐Orgs) and hepatocyte‐like cells (iHep) are generated as cellular models for studying hepatic pathology. DGUOK mutant iHep and iHep‐Orgs, but not control and corrected one, are more sensitive to iron overload‐induced ferroptosis, which can be rescued by N‐Acetylcysteine (NAC). Mechanically, this ferroptosis is a process mediated by nuclear receptor co‐activator 4 (NCOA4)‐dependent degradation of ferritin in lysosome and cellular labile iron release. This study reveals the underlying pathological mechanisms and the viable therapeutic strategies of this syndrome, and is the first pure iHep‐Orgs model in hereditary liver diseases. John Wiley and Sons Inc. 2021-03-08 /pmc/articles/PMC8132052/ /pubmed/34026460 http://dx.doi.org/10.1002/advs.202004680 Text en © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Guo, Jingyi Duan, Lifan He, Xueying Li, Shengbiao Wu, Yi Xiang, Ge Bao, Feixiang Yang, Liang Shi, Hongyan Gao, Mi Zheng, Lingjun Hu, Huili Liu, Xingguo A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome |
title | A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome |
title_full | A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome |
title_fullStr | A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome |
title_full_unstemmed | A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome |
title_short | A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome |
title_sort | combined model of human ipsc‐derived liver organoids and hepatocytes reveals ferroptosis in dguok mutant mtdna depletion syndrome |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132052/ https://www.ncbi.nlm.nih.gov/pubmed/34026460 http://dx.doi.org/10.1002/advs.202004680 |
work_keys_str_mv | AT guojingyi acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT duanlifan acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT hexueying acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT lishengbiao acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT wuyi acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT xiangge acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT baofeixiang acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT yangliang acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT shihongyan acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT gaomi acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT zhenglingjun acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT huhuili acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT liuxingguo acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT guojingyi combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT duanlifan combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT hexueying combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT lishengbiao combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT wuyi combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT xiangge combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT baofeixiang combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT yangliang combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT shihongyan combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT gaomi combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT zhenglingjun combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT huhuili combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome AT liuxingguo combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome |